Accipiter Biosciences Inc. — Form D

Accipiter Biosciences Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2026-07-28. The offering totals $10.5M, of which $10.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Jose Antonio Mesa CejudoRelated PersonSeattle, WA
Matthew BickRelated PersonSeattle, WA
William CanestaroRelated PersonSeattle, WA
Javier CastellanosRelated PersonSeattle, WA
Hector De Jesus Rincon AranoRelated PersonSeattle, WA
Heather RedmanRelated PersonSeattle, WA
Randall SchatzmanRelated PersonSeattle, WA
Heather GorhamDirectorSeattle, WA
Jose Antonio Mesa CejudoDirectorSeattle, WA
Jiaping GuDirectorSeattle, WA
Matthew BickDirectorSeattle, WA
Matthew BickExecutive OfficerSeattle, WA
Matthew BickPromoterSeattle, WA
Javier CastellanosDirectorSeattle, WA
Javier CastellanosExecutive OfficerSeattle, WA
Javier CastellanosPromoterSeattle, WA
Hector De Jesus Rincon AranoExecutive OfficerSeattle, WA
Hector De Jesus Rincon AranoPromoterSeattle, WA
William ArthurDirectorBainbridge, WA
William ArthurExecutive OfficerBainbridge, WA
William ArthurPromoterBainbridge, WA
Hector AranoDirectorBainbridge, WA
Hector AranoExecutive OfficerBainbridge, WA
Hector AranoPromoterBainbridge, WA

Other filings by this issuer (3)

FiledFormOfferingSold
2025-09-24D/A$13.7M$13.6M
2024-05-28D$13.7M$7.9M
2023-05-02D$1.0M$650K

More